CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 98 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2018. The put-call ratio across all filers is 0.96 and the average weighting 1.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TSP Capital Management Group, LLC | 876,020 | $31,037,000 | 13.97% |
Private Capital Advisors, Inc. | 173,191 | $6,136,000 | 2.23% |
ARDSLEY ADVISORY PARTNERS LP | 265,000 | $9,389,000 | 1.92% |
SECTORAL ASSET MANAGEMENT INC | 944,522 | $33,464,000 | 1.61% |
EMERALD MUTUAL FUND ADVISERS TRUST | 446,824 | $15,830,000 | 1.09% |
KOPP INVESTMENT ADVISORS LLC | 72,755 | $2,578,000 | 0.95% |
EMERALD ADVISERS, LLC | 455,619 | $16,143,000 | 0.91% |
Cupps Capital Management, LLC | 254,655 | $9,022,000 | 0.58% |
HealthCor Management, L.P. | 300,000 | $10,629,000 | 0.57% |
EAM Investors, LLC | 79,486 | $2,816,000 | 0.56% |